维普中文期刊产品整合服务
572篇 您的检索式:作者名="Defronzo RA"
    题名 作者 年代 出处 被引量
1Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type显示文摘Miyazaki Y DeFronzo RA 2009Cardiovase Diabetol2009,8,:1
2From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus显示文摘Defronzo RA Banting Lecture 2009Diabetes2009,58,4:1
3Pharmacologic therapy for type 2 diabetes mellitus显示文摘DeFronzo RA 1999Ann Intern Med1999,131,4:1
4The effect of insulin on renal sodium metabolism: a review with clinical implications 显示文摘DeFronzo RA 1981Diabetologia1981,21,2:1
5Effects of exenatide(exendin- 4) on glycemic control and weight over 30 weeks in meffonnin-treated patients with type 2 diabetes显示文摘DeFronzo RA Ratner RE Han J 2005Diabetes Care2005,28,5:1
6Impaired fasting glucose and impaired glueosetoleranee: implications for care 显示文摘Nathan DM Davidson MB DeFronzo RA 2007Diabetes Care2007,30,3:1
7Pharmacologic therapy for type 2 diabetes mellitus 显示文摘DeFronzo RA 1999Ann Intern Med1999,131,4:1
8Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglyeemic insulin clamp显示文摘Matsuda M DeFronzo RA 1999Diabetes Care1999,22,:1
9Contributions ofβcell dysfunction and insulin resistance to the pathogenesis of IGT and IFG显示文摘Abdul-Ghani MA Tripathy D DeFronzo RA 0,,05:1
10Ne- phropathy in diabetes 显示文摘Moliteh ME DeFronzo RA Franz MJ 2004Diabetes Care2004,27,1:1
11Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance显示文摘Haus JM Kashyap SR Kasumov T Zhang R Kelly KR Defronzo RA 2009Diabetes2009,58,2:1
12Glucose toxicity ( review ) 显示文摘ROSSETTI L GIACCARI A DEFRONZO RA 1990Diabeties Care1990,13,6:1
13Efficacy andsafety of SGLT2 inhibitors in the treatment of type 2 dia-betes mellitus显示文摘Abdul-Ghani MA Norton L DeFronzo RA 2012Curr Diab Rep2012,12,3:1
14Assessment and treatment of cardiovascular risk in prediabetes : impaired glucose tolerance and impaired fasting glucose显示文摘DeFronzo RA Abdul-Ghani M 2011Am J Cardiol2011,108,:1
15Glucose clamp technique a method for quantifying insulin secretion and resistance显示文摘DeFronzo RA Tobin JD Andres R 0,,:1
16The efficacy and safetyof saxagliptin when added to metformin therapy in patients withinadequately controlled type 2 diabetes with metformin alone显示文摘DeFronzo RA Hissa MN Garber AJ 2009Diabetes Care2009,32,:1
17Glucose clamp technique: a method for quantifying insulin secretion and resistance显示文摘Defronzo RA Tobin JD Andres R 1979Am J Physiol1979,237,3:1
18The insulin resistance syndrome:physiological considerations显示文摘Kashyap SR Defronzo RA 2007Diab Vasc Dis Res2007,4,1:1
19Assessment and treatment of cardiovas- cular risk in prediabetes: impaired glucose tolerance and impaired fast- ing glucose显示文摘DeFronzo RA Abdul-Ghani M 2011Am J Cardiol2011,108,3:1
20The insulin resistance syndrome:physiological considerations显示文摘Kashyap SR Defronzo RA 2007Diab Vasc Dis Res2007,4,1:1
返回顶部 每页显示:
共29页 首页 上一页 第1页 下一页 末页 /29 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费